On Friday, the FDA expanded its approved use for kids 6 years and older who have Type 1 diabetes or those who require insulin ...

MannKind posted Phase 3 trial results last October, comparing Afrezza in patients aged 4 to 17, with multiple daily insulin ...

This article is part of “Innovations In: Type 1 Diabetes,” an editorially independent special report that was produced with financial support from Vertex. On one wall of endocrinologist Kevan Herold’s ...

With better screening for type 1 diabetes and a new treatment called TZield, the outlook is improving for people with the ...

Treatment-induced neuropathy of diabetes (TIND) is a rare but potentially painful complication of diabetes caused by high blood sugar and nerve damage. Treatment-induced neuropathy of diabetes (TIND) ...

NewcelX Ltd. NCEL, a regenerative medicine company, on Wednesday announced the submission of a Pre-IND briefing package to ...

Johns Hopkins engineers are developing treatments for Type 1 diabetes that don't rely on daily insulin injections or wearing an insulin pump to manage blood sugar levels. Instead, their new cell-based ...

As multiple organs can be affected by diabetes, treatment nowadays extends beyond just controlling blood sugar levels.

It’s likely you’ve gotten into a rhythm when it comes to managing your type 2 diabetes (T2D). Yet, between your medication and lifestyle habits, treatment isn’t always a “set it and forget it” type of ...

More than 5.8 million people are thought to be living with diabetes in the UK and 90% of cases are type 2. This form of the ...

Metformin is particularly effective for people with diabetes or prediabetes who have obesity and have difficulty managing their blood sugar through lifestyle changes alone. Metformin is a widely used ...

Management of dry mouth through adequate hydration, sugar-free saliva stimulants, saliva substitutes, and fluoride ...